title: Polymer micelles with hydrazone-ester dual linkers for tunable release of dexamethasone.
abstract: OBJECTIVE
  To develop polymer micelles for the tunable release of Dexamethasone (DEX) in tumors.
  
  
  METHODS
  DEX was conjugated to poly(ethylene glycol)-poly(aspartate) block copolymers using hydrazone, ester, or hydrazone-ester dual linkers. Ketonic acids containing 3, 4, and 5 methylene groups were used as spacers to separate the dual linkers. Polymer micelles from the DEX-conjugated polymers were tested for drug release at different pH values and carboxylesterase activity levels.
  
  
  RESULTS
  DLS measurements and (1)H-NMR analysis confirmed all DEX-loaded micelles were <100 nm with core-shell structure. Single linker micelles appeared unsuitable to release DEX preferentially in acidic tumor tissues. Hydrazone linkages between DEX and polymers were non-degradable at both pH 7.4 and 5.0. Ester linkages stable at pH 5.0 were unstable at pH 7.4. Hydrazone-ester dual linkers suppressed DEX release at pH 7.4 while accelerating drug release at pH 5.0. DEX release decreased at pH 5.0 as the length of ketonic acid increased but was independent of spacer length at pH 7.4. Dual linker micelles were stable in the presence of carboxylesterases, suggesting DEX release was primarily due to pH-dependent hydrolysis.
  
  
  CONCLUSIONS
  Tunable release of DEX was achieved using pH-sensitive polymer micelles with hydrazone-ester dual linkers.
authors: Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone, Lexington, KY 40536-0596, USA.
authors: Melissa D
authors: MD
authors: Howard
authors: Andrei
authors: A
authors: Ponta
authors: Allison
authors: A
authors: Eckman
authors: Michael
authors: M
authors: Jay
authors: Younsoo
authors: Y
authors: Bae
references: Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3460-5
references: 17307870
references: J Control Release. 2004 Mar 24;95(3):613-26
references: 15023471
references: Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4607-12
references: 9539785
references: Pharm Res. 2010 Nov;27(11):2330-42
references: 20372992
references: Clin Cancer Res. 2004 Mar 1;10(5):1633-44
references: 15014014
references: Cancer Res. 1986 Dec;46(12 Pt 1):6387-92
references: 2946403
references: Adv Drug Deliv Rev. 1997 Jul 7;26(2-3):71-90
references: 10837535
references: Biochem Pharmacol. 2005 Nov 25;70(11):1673-84
references: 16213467
references: Br J Cancer. 2002 Sep 9;87(6):659-64
references: 12237777
references: Anesth Analg. 2007 May;104(5):1052-8, tables of contents
references: 17456652
references: Bioconjug Chem. 2007 Mar-Apr;18(2):363-70
references: 17309227
references: Nat Rev Cancer. 2006 Jul;6(7):546-58
references: 16794637
references: Pharm Res. 1996 Jun;13(6):820-31
references: 8792417
references: J Biomed Mater Res. 1987 Nov;21(11):1341-58
references: 3680316
references: Mol Membr Biol. 2010 Oct;27(7):353-63
references: 20939771
references: Adv Drug Deliv Rev. 2009 Aug 10;61(10):768-84
references: 19422866
references: J Immunol. 2000 Feb 15;164(4):1768-74
references: 10657623
references: Pharm Res. 2010 Nov;27(11):2421-32
references: 20700632
references: J Pharm Sci. 2001 Jun;90(6):667-80
references: 11357170
references: Curr Pharm Des. 2006;12(36):4669-84
references: 17168771
references: Cancer Res. 1993 Oct 15;53(20):4764-6
references: 8402656
references: Eur J Pharm Sci. 2009 Jun 28;37(3-4):405-12
references: 19491032
references: Cancer Sci. 2009 Apr;100(4):572-9
references: 19462526
references: Neuro Oncol. 2006 Jul;8(3):227-33
references: 16775223
references: Bioconjug Chem. 2005 Jan-Feb;16(1):122-30
references: 15656583
references: J Control Release. 2008 Dec 18;132(3):164-70
references: 18571265
references: Bioconjug Chem. 2007 Jul-Aug;18(4):1131-9
references: 17488066
references: J Pharm Sci. 1998 Jul;87(7):880-5
references: 9649358
references: Crit Rev Ther Drug Carrier Syst. 1999;16(3):245-88
references: 10706520
references: J Natl Cancer Inst. 2006 Mar 1;98(5):335-44
references: 16507830
references: J Pharm Sci. 1994 Apr;83(4):601-6
references: 8046623
references: Science. 2009 May 22;324(5930):1029-33
references: 19460998
references: Curr Drug Discov Technol. 2005 Sep;2(3):123-60
references: 16472224
references: Arthritis Res Ther. 2007;9(1):R2
references: 17233911
references: Pharm Res. 2008 Dec;25(12):2910-9
references: 18649124
references: Biomaterials. 2010 Mar;31(7):1765-72
references: 19959225
references: Int J Oncol. 2007 Apr;30(4):947-53
references: 17332934
references: Cell. 2000 Jan 7;100(1):57-70
references: 10647931
references: Nat Rev Drug Discov. 2003 May;2(5):347-60
references: 12750738
references: Angew Chem Int Ed Engl. 2003 Oct 6;42(38):4640-3
references: 14533151
references: J Control Release. 2007 Oct 8;122(3):324-30
references: 17669540
references: Nat Rev Cancer. 2006 Sep;6(9):688-701
references: 16900224
references: J Pharmacokinet Biopharm. 1995 Aug;23(4):397-406
references: 8882747
references: Science. 1995 Oct 13;270(5234):286-90
references: 7569976
references: J Control Release. 2001 Jun 15;73(2-3):137-72
references: 11516494
references: Mol Cancer Ther. 2006 May;5(5):1136-44
references: 16731745
references: Adv Drug Deliv Rev. 2001 Mar 23;47(1):113-31
references: 11251249